A Rip Van Winkle Portfolio: Invest In These Companies And Forget You Did It
Long-term investments in top tech, health, and consumer staples for stability, growth, and reliable returns. Read what ...
European shares tipped to soar as US investors pile in - experts reveal the cheap stocks they would buy
Where could be the top place to invest this spring? Europe. That's according to the latest edition of the hugely influential ...
European stocks are set to soar as US investors pile in. Here the world's top experts reveal the dirt-cheap stocks that could make YOU a packet
Where could be the top place to invest this spring? Europe. That's according to the latest edition of the hugely influential ...
Trump raises threat of higher tariffs on more goods into the US
US President Donald Trump has signalled plans to impose a 25% tariff on car imports, along with similar or higher levies on ...
3 Hot Stocks That Have Already Doubled in 2025
It may be early, but some blazing investments have already delivered wealth-altering gains in this young year.
3 hot US stocks that have already doubled in 2025
These super high-flying US stocks have soared 222%, 122%, and 150%, respectively, in 2025. Let's take a look why.
Novo Nordisk alleges fraud after $1.3 billion deal to buy hypertension drug from KBP Biosciences
Novo Nordisk is seeking up to $830 million in damages from KBP Biosciences, according to a ruling by a Singapore court, as ...
FierceBiotech18h
Novo Nordisk to sue KBP Biosciences over alleged fraudulent claims on kidney disease drug
After its potential kidney disease drug went down in flames late last year, Novo Nordisk is pinning the blame on alleged fraudulent claims by the drug’s original maker. | After its potential kidney ...
ENDPOINTS NEWS18h
No­vo looks to re­coup $830M from hy­per­ten­sion drug part­ner, claim­ing fraud
A judge in Singapore ordered the freezing of KBP Biosciences’ assets while Novo Nordisk pursues $830 million in damages over claims that it was deceived in a 2023 licensing deal.